Evidence map›Paper›PMID 37418678›Full record

ArticleBiochemistry2023

Kinetic and Structural Characterization of

Kayla Glockzin, Kathleen M Meneely, Ryan Hughes, Sean W Maatouk, Grace E Piña, Kajitha Suthagar, Keith Clinch, Joshua N Buckler, Audrey L Lamb, Peter C Tyler and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Kayla GlockzinDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.ORCID 0000-0003-2406-532X
Kathleen M MeneelyDepartment of Chemistry, University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249, United States.ORCID 0000-0002-0372-9695
Ryan HughesDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.
Sean W MaatoukDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.ORCID 0000-0002-4171-8057
Grace E PiñaDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.ORCID 0000-0003-4344-1458
Kajitha SuthagarFerrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, 69 Gracefield Road, Gracefield, Lower Hutt 5010, New Zealand.
Keith ClinchFerrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, 69 Gracefield Road, Gracefield, Lower Hutt 5010, New Zealand.
Joshua N BucklerFerrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, 69 Gracefield Road, Gracefield, Lower Hutt 5010, New Zealand.ORCID 0000-0002-4397-9947
Audrey L LambDepartment of Chemistry, University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249, United States.ORCID 0000-0002-2352-2130
Peter C TylerFerrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, 69 Gracefield Road, Gracefield, Lower Hutt 5010, New Zealand.ORCID 0000-0002-3151-6208
Thomas D MeekDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.
Ardala KatzfussDepartment of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Boulevard, College Station, Texas 77843-2128, United States.ORCID 0000-0002-7177-9600
Texas A&M University · USVictoria University of Wellington · NZThe University of Texas at San Antonio · US

Funding

PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASER01AI127807 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI MEEK, THOMAS, SCHRAMM, VERN L. · 2017 to 2021
$5.2M
NIAID NIH HHS R01 AI127807
6 · The paper itself

Abstract

Over 70 million people are currently at risk of developing Chagas Disease (CD) infection, with more than 8 million people already infected worldwide. Current treatments are limited and innovative therapies are required.

Indexed as

Trypanosoma cruziGuanineHumansPentosyltransferasesPurinesGuaninehypoxanthine-guanine-xanthine phosphoribosyltransferasePentosyltransferasesPurines

Identifiers

PMID37418678
PMCPMC10357585
OpenAlexW4383500153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.